Global Compound Bone Peptide for Injection Supply, Demand and Key Producers, 2024-2030

Description

The global Compound Bone Peptide for Injection market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Compound bone peptide preparation, wherein, the compound bone peptide preparation is produced by mixing bone peptide extracting solution and scorpion extracting solution, performing acid treatment and alkali treatment to the mixed solution in sequence, regulating the pH value of the mixed solution after the alkali treatment is performed to be neutral, and ensuring the mixed solution with neutral pH value to contact with active carbon. The compound bone peptide preparation of the invention can be produced to be small capacity injection and freeze-dried powder injection. Compared with the prior method that the bone peptide extracting solution and the scorpion extracting solution are respectively and singly treated and then mixed, the compound bone peptide preparation provided by the invention is produced through acid precipitation, alkali precipitation and active carbon adsorption to the mixed solution of the bone peptide extracting solution and the scorpion extracting solution, can effectively remove impurity generated through the interaction because of the mixing of the bone peptide extracting solution and the scorpion extracting solution, and thereby obviously improving the clarity and reducing the injection irritability of the compound bone peptide preparation (namely improving the injection compliance).

This report studies the global Compound Bone Peptide for Injection production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Compound Bone Peptide for Injection, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Compound Bone Peptide for Injection that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Compound Bone Peptide for Injection total production and demand, 2019-2030, (K Units)
Global Compound Bone Peptide for Injection total production value, 2019-2030, (USD Million)
Global Compound Bone Peptide for Injection production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Compound Bone Peptide for Injection consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Compound Bone Peptide for Injection domestic production, consumption, key domestic manufacturers and share
Global Compound Bone Peptide for Injection production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Compound Bone Peptide for Injection production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Compound Bone Peptide for Injection production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Compound Bone Peptide for Injection market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jiangshi Pharma, Zhitong Biopharma and Xinbai Pharmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Compound Bone Peptide for Injection market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Compound Bone Peptide for Injection Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Compound Bone Peptide for Injection Market, Segmentation by Type
    Intramuscular Injection
    Intravenous Drip

Global Compound Bone Peptide for Injection Market, Segmentation by Application
    Rheumatism
    Rheumatoid Arthritis
    Osteoporosis
    Cervical spondylosis
    Post-fracture healing
    Others

Companies Profiled:
    Jiangshi Pharma
    Zhitong Biopharma
    Xinbai Pharmaceutical

Key Questions Answered
1. How big is the global Compound Bone Peptide for Injection market?
2. What is the demand of the global Compound Bone Peptide for Injection market?
3. What is the year over year growth of the global Compound Bone Peptide for Injection market?
4. What is the production and production value of the global Compound Bone Peptide for Injection market?
5. Who are the key producers in the global Compound Bone Peptide for Injection market?

Table of Contents

1 Supply Summary
    1.1 Compound Bone Peptide for Injection Introduction
    1.2 World Compound Bone Peptide for Injection Supply & Forecast
        1.2.1 World Compound Bone Peptide for Injection Production Value (2019 & 2023 & 2030)
        1.2.2 World Compound Bone Peptide for Injection Production (2019-2030)
        1.2.3 World Compound Bone Peptide for Injection Pricing Trends (2019-2030)
    1.3 World Compound Bone Peptide for Injection Production by Region (Based on Production Site)
        1.3.1 World Compound Bone Peptide for Injection Production Value by Region (2019-2030)
        1.3.2 World Compound Bone Peptide for Injection Production by Region (2019-2030)
        1.3.3 World Compound Bone Peptide for Injection Average Price by Region (2019-2030)
        1.3.4 North America Compound Bone Peptide for Injection Production (2019-2030)
        1.3.5 Europe Compound Bone Peptide for Injection Production (2019-2030)
        1.3.6 China Compound Bone Peptide for Injection Production (2019-2030)
        1.3.7 Japan Compound Bone Peptide for Injection Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Compound Bone Peptide for Injection Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Compound Bone Peptide for Injection Major Market Trends

2 Demand Summary
    2.1 World Compound Bone Peptide for Injection Demand (2019-2030)
    2.2 World Compound Bone Peptide for Injection Consumption by Region
        2.2.1 World Compound Bone Peptide for Injection Consumption by Region (2019-2024)
        2.2.2 World Compound Bone Peptide for Injection Consumption Forecast by Region (2025-2030)
    2.3 United States Compound Bone Peptide for Injection Consumption (2019-2030)
    2.4 China Compound Bone Peptide for Injection Consumption (2019-2030)
    2.5 Europe Compound Bone Peptide for Injection Consumption (2019-2030)
    2.6 Japan Compound Bone Peptide for Injection Consumption (2019-2030)
    2.7 South Korea Compound Bone Peptide for Injection Consumption (2019-2030)
    2.8 ASEAN Compound Bone Peptide for Injection Consumption (2019-2030)
    2.9 India Compound Bone Peptide for Injection Consumption (2019-2030)

3 World Compound Bone Peptide for Injection Manufacturers Competitive Analysis
    3.1 World Compound Bone Peptide for Injection Production Value by Manufacturer (2019-2024)
    3.2 World Compound Bone Peptide for Injection Production by Manufacturer (2019-2024)
    3.3 World Compound Bone Peptide for Injection Average Price by Manufacturer (2019-2024)
    3.4 Compound Bone Peptide for Injection Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Compound Bone Peptide for Injection Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Compound Bone Peptide for Injection in 2023
        3.5.3 Global Concentration Ratios (CR8) for Compound Bone Peptide for Injection in 2023
    3.6 Compound Bone Peptide for Injection Market: Overall Company Footprint Analysis
        3.6.1 Compound Bone Peptide for Injection Market: Region Footprint
        3.6.2 Compound Bone Peptide for Injection Market: Company Product Type Footprint
        3.6.3 Compound Bone Peptide for Injection Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Compound Bone Peptide for Injection Production Value Comparison
        4.1.1 United States VS China: Compound Bone Peptide for Injection Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Compound Bone Peptide for Injection Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Compound Bone Peptide for Injection Production Comparison
        4.2.1 United States VS China: Compound Bone Peptide for Injection Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Compound Bone Peptide for Injection Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Compound Bone Peptide for Injection Consumption Comparison
        4.3.1 United States VS China: Compound Bone Peptide for Injection Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Compound Bone Peptide for Injection Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Compound Bone Peptide for Injection Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Compound Bone Peptide for Injection Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Compound Bone Peptide for Injection Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Compound Bone Peptide for Injection Production (2019-2024)
    4.5 China Based Compound Bone Peptide for Injection Manufacturers and Market Share
        4.5.1 China Based Compound Bone Peptide for Injection Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Compound Bone Peptide for Injection Production Value (2019-2024)
        4.5.3 China Based Manufacturers Compound Bone Peptide for Injection Production (2019-2024)
    4.6 Rest of World Based Compound Bone Peptide for Injection Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Compound Bone Peptide for Injection Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Compound Bone Peptide for Injection Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Compound Bone Peptide for Injection Production (2019-2024)

5 Market Analysis by Type
    5.1 World Compound Bone Peptide for Injection Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Intramuscular Injection
        5.2.2 Intravenous Drip
    5.3 Market Segment by Type
        5.3.1 World Compound Bone Peptide for Injection Production by Type (2019-2030)
        5.3.2 World Compound Bone Peptide for Injection Production Value by Type (2019-2030)
        5.3.3 World Compound Bone Peptide for Injection Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Compound Bone Peptide for Injection Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Rheumatism
        6.2.2 Rheumatoid Arthritis
        6.2.3 Osteoporosis
        6.2.4 Cervical spondylosis
        6.2.5 Post-fracture healing
        6.2.6 Others
    6.3 Market Segment by Application
        6.3.1 World Compound Bone Peptide for Injection Production by Application (2019-2030)
        6.3.2 World Compound Bone Peptide for Injection Production Value by Application (2019-2030)
        6.3.3 World Compound Bone Peptide for Injection Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Jiangshi Pharma
        7.1.1 Jiangshi Pharma Details
        7.1.2 Jiangshi Pharma Major Business
        7.1.3 Jiangshi Pharma Compound Bone Peptide for Injection Product and Services
        7.1.4 Jiangshi Pharma Compound Bone Peptide for Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Jiangshi Pharma Recent Developments/Updates
        7.1.6 Jiangshi Pharma Competitive Strengths & Weaknesses
    7.2 Zhitong Biopharma
        7.2.1 Zhitong Biopharma Details
        7.2.2 Zhitong Biopharma Major Business
        7.2.3 Zhitong Biopharma Compound Bone Peptide for Injection Product and Services
        7.2.4 Zhitong Biopharma Compound Bone Peptide for Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Zhitong Biopharma Recent Developments/Updates
        7.2.6 Zhitong Biopharma Competitive Strengths & Weaknesses
    7.3 Xinbai Pharmaceutical
        7.3.1 Xinbai Pharmaceutical Details
        7.3.2 Xinbai Pharmaceutical Major Business
        7.3.3 Xinbai Pharmaceutical Compound Bone Peptide for Injection Product and Services
        7.3.4 Xinbai Pharmaceutical Compound Bone Peptide for Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Xinbai Pharmaceutical Recent Developments/Updates
        7.3.6 Xinbai Pharmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Compound Bone Peptide for Injection Industry Chain
    8.2 Compound Bone Peptide for Injection Upstream Analysis
        8.2.1 Compound Bone Peptide for Injection Core Raw Materials
        8.2.2 Main Manufacturers of Compound Bone Peptide for Injection Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Compound Bone Peptide for Injection Production Mode
    8.6 Compound Bone Peptide for Injection Procurement Model
    8.7 Compound Bone Peptide for Injection Industry Sales Model and Sales Channels
        8.7.1 Compound Bone Peptide for Injection Sales Model
        8.7.2 Compound Bone Peptide for Injection Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Compound Bone Peptide for Injection Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Compound Bone Peptide for Injection Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Compound Bone Peptide for Injection Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Compound Bone Peptide for Injection Production Value Market Share by Region (2019-2024)
    Table 5. World Compound Bone Peptide for Injection Production Value Market Share by Region (2025-2030)
    Table 6. World Compound Bone Peptide for Injection Production by Region (2019-2024) & (K Units)
    Table 7. World Compound Bone Peptide for Injection Production by Region (2025-2030) & (K Units)
    Table 8. World Compound Bone Peptide for Injection Production Market Share by Region (2019-2024)
    Table 9. World Compound Bone Peptide for Injection Production Market Share by Region (2025-2030)
    Table 10. World Compound Bone Peptide for Injection Average Price by Region (2019-2024) & (US$/Unit)
    Table 11. World Compound Bone Peptide for Injection Average Price by Region (2025-2030) & (US$/Unit)
    Table 12. Compound Bone Peptide for Injection Major Market Trends
    Table 13. World Compound Bone Peptide for Injection Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
    Table 14. World Compound Bone Peptide for Injection Consumption by Region (2019-2024) & (K Units)
    Table 15. World Compound Bone Peptide for Injection Consumption Forecast by Region (2025-2030) & (K Units)
    Table 16. World Compound Bone Peptide for Injection Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Compound Bone Peptide for Injection Producers in 2023
    Table 18. World Compound Bone Peptide for Injection Production by Manufacturer (2019-2024) & (K Units)
    Table 19. Production Market Share of Key Compound Bone Peptide for Injection Producers in 2023
    Table 20. World Compound Bone Peptide for Injection Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 21. Global Compound Bone Peptide for Injection Company Evaluation Quadrant
    Table 22. World Compound Bone Peptide for Injection Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Compound Bone Peptide for Injection Production Site of Key Manufacturer
    Table 24. Compound Bone Peptide for Injection Market: Company Product Type Footprint
    Table 25. Compound Bone Peptide for Injection Market: Company Product Application Footprint
    Table 26. Compound Bone Peptide for Injection Competitive Factors
    Table 27. Compound Bone Peptide for Injection New Entrant and Capacity Expansion Plans
    Table 28. Compound Bone Peptide for Injection Mergers & Acquisitions Activity
    Table 29. United States VS China Compound Bone Peptide for Injection Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Compound Bone Peptide for Injection Production Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 31. United States VS China Compound Bone Peptide for Injection Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 32. United States Based Compound Bone Peptide for Injection Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Compound Bone Peptide for Injection Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Compound Bone Peptide for Injection Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Compound Bone Peptide for Injection Production (2019-2024) & (K Units)
    Table 36. United States Based Manufacturers Compound Bone Peptide for Injection Production Market Share (2019-2024)
    Table 37. China Based Compound Bone Peptide for Injection Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Compound Bone Peptide for Injection Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Compound Bone Peptide for Injection Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Compound Bone Peptide for Injection Production (2019-2024) & (K Units)
    Table 41. China Based Manufacturers Compound Bone Peptide for Injection Production Market Share (2019-2024)
    Table 42. Rest of World Based Compound Bone Peptide for Injection Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Compound Bone Peptide for Injection Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Compound Bone Peptide for Injection Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Compound Bone Peptide for Injection Production (2019-2024) & (K Units)
    Table 46. Rest of World Based Manufacturers Compound Bone Peptide for Injection Production Market Share (2019-2024)
    Table 47. World Compound Bone Peptide for Injection Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Compound Bone Peptide for Injection Production by Type (2019-2024) & (K Units)
    Table 49. World Compound Bone Peptide for Injection Production by Type (2025-2030) & (K Units)
    Table 50. World Compound Bone Peptide for Injection Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Compound Bone Peptide for Injection Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Compound Bone Peptide for Injection Average Price by Type (2019-2024) & (US$/Unit)
    Table 53. World Compound Bone Peptide for Injection Average Price by Type (2025-2030) & (US$/Unit)
    Table 54. World Compound Bone Peptide for Injection Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World Compound Bone Peptide for Injection Production by Application (2019-2024) & (K Units)
    Table 56. World Compound Bone Peptide for Injection Production by Application (2025-2030) & (K Units)
    Table 57. World Compound Bone Peptide for Injection Production Value by Application (2019-2024) & (USD Million)
    Table 58. World Compound Bone Peptide for Injection Production Value by Application (2025-2030) & (USD Million)
    Table 59. World Compound Bone Peptide for Injection Average Price by Application (2019-2024) & (US$/Unit)
    Table 60. World Compound Bone Peptide for Injection Average Price by Application (2025-2030) & (US$/Unit)
    Table 61. Jiangshi Pharma Basic Information, Manufacturing Base and Competitors
    Table 62. Jiangshi Pharma Major Business
    Table 63. Jiangshi Pharma Compound Bone Peptide for Injection Product and Services
    Table 64. Jiangshi Pharma Compound Bone Peptide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. Jiangshi Pharma Recent Developments/Updates
    Table 66. Jiangshi Pharma Competitive Strengths & Weaknesses
    Table 67. Zhitong Biopharma Basic Information, Manufacturing Base and Competitors
    Table 68. Zhitong Biopharma Major Business
    Table 69. Zhitong Biopharma Compound Bone Peptide for Injection Product and Services
    Table 70. Zhitong Biopharma Compound Bone Peptide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. Zhitong Biopharma Recent Developments/Updates
    Table 72. Xinbai Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 73. Xinbai Pharmaceutical Major Business
    Table 74. Xinbai Pharmaceutical Compound Bone Peptide for Injection Product and Services
    Table 75. Xinbai Pharmaceutical Compound Bone Peptide for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 76. Global Key Players of Compound Bone Peptide for Injection Upstream (Raw Materials)
    Table 77. Compound Bone Peptide for Injection Typical Customers
    Table 78. Compound Bone Peptide for Injection Typical Distributors
List of Figure
    Figure 1. Compound Bone Peptide for Injection Picture
    Figure 2. World Compound Bone Peptide for Injection Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Compound Bone Peptide for Injection Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Compound Bone Peptide for Injection Production (2019-2030) & (K Units)
    Figure 5. World Compound Bone Peptide for Injection Average Price (2019-2030) & (US$/Unit)
    Figure 6. World Compound Bone Peptide for Injection Production Value Market Share by Region (2019-2030)
    Figure 7. World Compound Bone Peptide for Injection Production Market Share by Region (2019-2030)
    Figure 8. North America Compound Bone Peptide for Injection Production (2019-2030) & (K Units)
    Figure 9. Europe Compound Bone Peptide for Injection Production (2019-2030) & (K Units)
    Figure 10. China Compound Bone Peptide for Injection Production (2019-2030) & (K Units)
    Figure 11. Japan Compound Bone Peptide for Injection Production (2019-2030) & (K Units)
    Figure 12. Compound Bone Peptide for Injection Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Compound Bone Peptide for Injection Consumption (2019-2030) & (K Units)
    Figure 15. World Compound Bone Peptide for Injection Consumption Market Share by Region (2019-2030)
    Figure 16. United States Compound Bone Peptide for Injection Consumption (2019-2030) & (K Units)
    Figure 17. China Compound Bone Peptide for Injection Consumption (2019-2030) & (K Units)
    Figure 18. Europe Compound Bone Peptide for Injection Consumption (2019-2030) & (K Units)
    Figure 19. Japan Compound Bone Peptide for Injection Consumption (2019-2030) & (K Units)
    Figure 20. South Korea Compound Bone Peptide for Injection Consumption (2019-2030) & (K Units)
    Figure 21. ASEAN Compound Bone Peptide for Injection Consumption (2019-2030) & (K Units)
    Figure 22. India Compound Bone Peptide for Injection Consumption (2019-2030) & (K Units)
    Figure 23. Producer Shipments of Compound Bone Peptide for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Compound Bone Peptide for Injection Markets in 2023
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Compound Bone Peptide for Injection Markets in 2023
    Figure 26. United States VS China: Compound Bone Peptide for Injection Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 27. United States VS China: Compound Bone Peptide for Injection Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Compound Bone Peptide for Injection Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. United States Based Manufacturers Compound Bone Peptide for Injection Production Market Share 2023
    Figure 30. China Based Manufacturers Compound Bone Peptide for Injection Production Market Share 2023
    Figure 31. Rest of World Based Manufacturers Compound Bone Peptide for Injection Production Market Share 2023
    Figure 32. World Compound Bone Peptide for Injection Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 33. World Compound Bone Peptide for Injection Production Value Market Share by Type in 2023
    Figure 34. Intramuscular Injection
    Figure 35. Intravenous Drip
    Figure 36. World Compound Bone Peptide for Injection Production Market Share by Type (2019-2030)
    Figure 37. World Compound Bone Peptide for Injection Production Value Market Share by Type (2019-2030)
    Figure 38. World Compound Bone Peptide for Injection Average Price by Type (2019-2030) & (US$/Unit)
    Figure 39. World Compound Bone Peptide for Injection Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 40. World Compound Bone Peptide for Injection Production Value Market Share by Application in 2023
    Figure 41. Rheumatism
    Figure 42. Rheumatoid Arthritis
    Figure 43. Osteoporosis
    Figure 44. Cervical spondylosis
    Figure 45. Post-fracture healing
    Figure 46. Others
    Figure 47. World Compound Bone Peptide for Injection Production Market Share by Application (2019-2030)
    Figure 48. World Compound Bone Peptide for Injection Production Value Market Share by Application (2019-2030)
    Figure 49. World Compound Bone Peptide for Injection Average Price by Application (2019-2030) & (US$/Unit)
    Figure 50. Compound Bone Peptide for Injection Industry Chain
    Figure 51. Compound Bone Peptide for Injection Procurement Model
    Figure 52. Compound Bone Peptide for Injection Sales Model
    Figure 53. Compound Bone Peptide for Injection Sales Channels, Direct Sales, and Distribution
    Figure 54. Methodology
    Figure 55. Research Process and Data Source

Companies Mentioned

Jiangshi Pharma
Zhitong Biopharma
Xinbai Pharmaceutical